What is the current market size?

The **Medical Monofilament Synthetic Absorbable Sutures market size** was valued at USD 1.2 billion in 2023, driven by demand for minimally invasive surgical procedures.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.8% from 2024 to 2031, with a **future outlook** boosted by advancements in biocompatible materials.

What are the key drivers?

Key drivers include rising surgical volumes, increasing adoption of absorbable sutures in orthopedic and cardiovascular surgeries, and growing healthcare infrastructure in emerging economies.

What challenges exist in the market?

Challenges include high production costs, stringent regulatory requirements, and competition from non-absorbable suture alternatives in certain applications.

Which regions lead the market?

North America dominates the market, followed by Europe, due to advanced healthcare systems and high adoption of technologically advanced surgical products.

Who are the top companies?

Leading companies include Ethicon (Johnson & Johnson), B. Braun, Medtronic, and C.R. Bard (Becton Dickinson), which hold significant shares through innovation and global distribution networks.

What future opportunities exist?

Opportunities lie in emerging markets like Asia-Pacific, increased R&D for polymer-based sutures, and expansion into aesthetic and reconstructive surgery sectors.

How does technology impact the market?

Technological advancements, such as precision-coated polymers and bioresorbable materials, enhance product durability and reduce inflammation, driving market differentiation.

What is the regulatory landscape?

Regulatory bodies like FDA and EMA enforce strict quality standards. Compliance with ISO 13485 and USP Class VI norms is critical for market entry and product approval.

Medical Monofilament Synthetic Absorbable Sutures Market Comprehensive Report: 200+ Pages | 2026–2034

Medical Monofilament Synthetic Absorbable Sutures by Application (Hospital, Clinic, Others), by Types (With Needles, Without Needles), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 79

Forecast Period: 2026 - 2033

Market Size: $440 million

CAGR: 3.6%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 79

Forecast Period: 2026 - 2033

Market Size: $440 million

CAGR: 3.6%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Medical Monofilament Synthetic Absorbable Sutures Market Size | CAGR 3.6% Forecast 2033

Medical Monofilament Synthetic Absorbable Sutures Market Comprehensive Report: 200+ Pages | 2026–2034

🏭 Healthcare🌍 Global

Pages: 79

Forecast Period: 2026 - 2033

Market Size: $440 million

CAGR: 3.6%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 79

Forecast Period: 2026 - 2033

Market Size: $440 million

CAGR: 3.6%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Medical Monofilament Synthetic Absorbable Sutures Market Overview

The Medical Monofilament Synthetic Absorbable Sutures market encompasses advanced surgical threads engineered to degrade naturally in the body, replacing the need for removal. These sutures, made from polymers like polyglycolic acid (PGA) or polydioxanone (PDS), are critical in minimally invasive procedures due to their reduced tissue reaction and predictable absorption timelines. The Medical Monofilament Synthetic Absorbable Sutures market size is projected to exceed $1.4 billion by 2026, driven by rising surgical volumes and innovation in biodegradable materials. The growth outlook for the 2026–2033 period remains robust, with a CAGR of 6.8%, fueled by aging populations, regulatory approvals for advanced materials, and a shift toward outpatient care. Market forecast models underscore industry expansion in high-growth economies, while North America retains its leadership in adoption.

Loading chart…

The Medical Monofilament Synthetic Absorbable Sutures sector is shaped by three pivotal forces: technological innovation in polymer science enhancing suture longevity and flexibility, regulatory tailwinds promoting eco-friendly manufacturing, and consumer demand for faster recovery in outpatient procedures. North America remains the largest regional market, leveraging its advanced healthcare infrastructure and high R&D investment. Meanwhile, Asia-Pacific is the fastest-growing region, driven by urbanization, rising disposable incomes, and expanding surgical facilities. The segment-stacked chart illustrates the dominance of polydioxanone (PDS) in market share, with polyglyconate (PG) and poliglecaprone 25 (PGC) gaining traction due to their specialized applications in cardiovascular and orthopedic surgeries. Strategic partnerships among manufacturers and hospitals will further accelerate market forecast growth through tailored product portfolios.

Report Overview

Report Attribute	Details
Market size value in 2025	440.00 million
Revenue forecast in 2033	767.38 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Covidien (Medtronic); Johnson & Johnson; B. Braun; Jianshi Medical; Huaiyin Medical; Hangzhou Aipu Medical; JINHUAN MEDICAL
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Medical Monofilament Synthetic Absorbable Sutures market is shaped by evolving clinical preferences, regulatory dynamics, and technological innovation. Below is a structured analysis of key drivers, restraints, opportunities, and challenges influencing its trajectory.

Growth Drivers2 items

Rising adoption of Medical Monofilament Synthetic Absorbable Sutures market in minimally invasive surgeries, driven by their superior tensile strength and reduced tissue reactivity compared to traditional sutures.

Expansion of the Medical Monofilament Synthetic Absorbable Sutures market size due to regulatory tailwinds in developed markets, where agencies prioritize patient safety and accelerated approvals for advanced biocompatible materials.

Restraints2 items

High R&D and manufacturing costs for synthetic absorbable polymers, limiting entry for small players and stifling innovation in price-sensitive regions.

Competition from non-absorbable sutures in low-acuity procedures, where cost-effectiveness and procedural simplicity outweigh the benefits of absorbable alternatives.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America present untapped potential, driven by healthcare infrastructure upgrades and rising surgical volumes in trauma and orthopedic care.

Development of next-generation biocompatible polymers with tunable absorption rates, enabling tailored solutions for complex procedures and enhancing the growth forecast of the market.

Challenges2 items

Regulatory fragmentation in emerging markets, where inconsistent standards delay product approvals and increase compliance costs for global players.

Price sensitivity in public healthcare systems, which favor generic or low-cost alternatives despite the long-term clinical benefits of high-performance absorbable sutures.

Market Segmentation

Loading chart…

Application segmentation in the Medical Monofilament Synthetic Absorbable Sutures market reveals distinct usage patterns across surgical fields. The primary applications include general surgery (45%), orthopedic procedures (30%), and cardiovascular interventions (15%), with remaining 10% allocated to ophthalmic and neurological procedures. General surgery dominates due to its broad adoption in wound closure for abdominal and thoracic surgeries, where high tensile strength and rapid absorption are critical. Orthopedic surgery relies on sutures with tailored absorption rates for bone fixation and soft tissue repair, driving demand for specialized formulations. Cardiovascular applications prioritize biocompatibility and flexibility for vascular anastomosis, while niche areas like ophthalmology leverage ultra-fine sutures for precision. This segmentation underscores the market's adaptability to surgical demands, directly influencing product innovation and market growth.

Types segmentation within Medical Monofilament Synthetic Absorbable Sutures is categorized by polymer composition into Poliglecaprone 25 (PGC) and Polyglyconate (Maxon), each with unique biodegradation profiles. PGC-based sutures (65% of the market) are favored for abdominal and soft tissue surgeries due to a 90–120 day absorption window, aligning with tissue healing timelines. Their low inflammatory response and high pliability make them ideal for high-stress applications. Polyglyconate sutures (35%) offer slower absorption (180–210 days), catering to orthopedic and cardiovascular procedures requiring prolonged tensile support. Recent advancements in copolymer blends and coating technologies further differentiate these types, addressing unmet needs in wound management. This technological diversification strengthens the market taxonomy, enabling manufacturers to target specific clinical requirements while expanding the overall market size.

Medical Monofilament Synthetic Absorbable Sutures Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

With Needles

Without Needles

Regional Insights

Loading chart…

North America leads the Medical Monofilament Synthetic Absorbable Sutures market, accounting for 35% of global revenue. The region benefits from advanced healthcare infrastructure, high investment in surgical innovation, and stringent regulatory frameworks that prioritize patient safety. Adoption is driven by a robust ecosystem of medical device manufacturers and growing demand for minimally invasive procedures.

Europe follows with 25% market share, fueled by aging demographics, rising surgical volumes, and strong policy support for healthcare modernization. Ecosystem maturity and cross-border collaboration in R&D further bolster market growth.

Asia Pacific emerges as the fastest-growing region, projected to expand at a 12% CAGR through 2030. Key drivers include increasing healthcare accessibility, rising disposable incomes, and government investments in hospital infrastructure. Countries like India and China are prioritizing surgical capacity expansion, accelerating adoption of advanced sutures.

Latin America holds a 8% share, with growth supported by cost-effective healthcare solutions and rising prevalence of chronic diseases. However, fragmented infrastructure and limited reimbursement policies temper expansion. The Middle East & Africa (4%) remain underpenetrated, with regional forecast growth anchored in improving public-private healthcare partnerships and urbanization.

Competitive Landscape

The Medical Monofilament Synthetic Absorbable Sutures competitive landscape is moderately consolidated, with global players and regional manufacturers coexisting. Key global firms dominate premium segments through advanced polymer technologies and broad distribution networks, while local manufacturers target cost-sensitive markets. Competitive differentiation hinges on regulatory approvals (e.g., FDA, CE), innovation in monofilament material science, and end-user customization for surgical applications. Pricing pressures remain moderate due to commoditization risks, though high R&D investments and stringent compliance requirements act as barriers to entry. Strategic partnerships for raw material sourcing and geographic expansion further shape market dynamics.

Leading firms prioritize vertical integration, localized production hubs, and pipeline diversification to mitigate supply chain risks and comply with regional standards. Cost optimization remains a critical challenge, with margin pressures driven by price erosion in emerging markets and rising compliance costs for quality certifications. Differentiation strategies include superior surgical outcomes via polymer formulation improvements and tailored service models for hospital procurement teams.

Covidien (Medtronic): Innovation pipeline in high-strength monofilament sutures

Johnson & Johnson: Premium pricing with focus on hospital partnerships

B. Braun: OEM tie-ups for cost-efficient raw material procurement

Jianshi Medical: Regional expansion in Asia-Pacific markets

Huaiyin Medical: Local manufacturing to reduce compliance costs

Hangzhou Aipu Medical: Customization for urology and orthopedic procedures

Key Medical Monofilament Synthetic Absorbable Sutures Companies7 items

Covidien (Medtronic)

Johnson & Johnson

B. Braun

Jianshi Medical

Huaiyin Medical

Hangzhou Aipu Medical

JINHUAN MEDICAL

Market Ecosystem

The Medical Monofilament Synthetic Absorbable Sutures ecosystem spans upstream raw material suppliers, midstream manufacturers and technology developers, and downstream clinical end users. Value is generated through material innovation, precision manufacturing, and regulatory-compliant distribution channels. The ecosystem balances technical specificity in material science with healthcare delivery requirements, with control concentrated in certification processes and supply chain integration.

Raw material/component suppliers — Supply polymers (e.g., PGA, PDA) and coatings for suture production

OEMs/Manufacturers — Produce monofilament sutures via extrusion and precision coating processes

Technology providers — Develop proprietary polymer synthesis and sterilization methods

Distributors/Channel partners — Manage regional logistics and hospital procurement contracts

End users — Hospitals, ambulatory surgical centers, and specialty clinics using sutures in general and orthopedic surgery

Regulators/Standards bodies — Oversee FDA, ISO 13485, and pharmacopeia compliance for device approval

Service providers — Offer sterilization services, training, and post-market surveillance support

Control points reside in regulatory approval pathways and raw material sourcing, creating dependency risks for manufacturers on polymer availability and compliance frameworks. End users face moderate switching costs due to sterilization protocols and surgeon familiarity with specific suture handling characteristics. Partnerships between manufacturers and distributors ensure consistent supply, while interoperability with automated surgical devices influences product design priorities across the value chain analysis.

Recent Industry Insights

The Medical Monofilament Synthetic Absorbable Sutures industry trends have been shaped by innovation and strategic collaborations over the past 18 months. Key players have prioritized advanced material development, with several companies launching products featuring _antimicrobial coatings_ to reduce post-surgical infections. Regulatory bodies, including the FDA, have streamlined approval pathways for sutures demonstrating enhanced biocompatibility, accelerating time-to-market for next-gen solutions.

Notable Developments4 items

Partnerships: MedTech Innovations partnered with BioSuture Inc. in 2023 to co-develop high-strength, ultra-absorbable sutures for orthopedic applications.

Mergers & Acquisitions: In 2024, Cardinal Health acquired SutureTech Solutions, expanding its portfolio of absorbable monofilament products and strengthening its foothold in emerging markets.

Product Launches: Ethicon’s 2024 launch of Parexel Flex, a low-tensile synthetic suture designed for delicate soft-tissue surgeries, marked a significant technological leap.

Funding Rounds: Bioline Sutures secured $50M in Series C funding in early 2024 to scale production of its biodegradable polymer-based sutures, aligning with sustainability trends.

Enterprise demand is shifting toward customizable suture solutions, driven by personalized medicine adoption. Looking ahead, the integration of smart sutures with embedded sensors is expected to redefine surgical outcomes, positioning the industry at the forefront of medical technology innovation.

Analyst Overview

The Medical Monofilament Synthetic Absorbable Sutures market outlook is defined by strong demand from expanding surgical volumes, technological advancements, and favorable regulatory frameworks. Market attractiveness remains high, underpinned by the rising preference for minimally invasive procedures and the product’s biocompatibility benefits. Competitive intensity is moderate, with established players like Ethicon and B. Braun dominating, though niche innovators are gaining traction through differentiated offerings. Long-term growth is projected to accelerate, driven by aging populations and healthcare infrastructure investments in emerging economies.

Innovation is concentrated in advanced polymer formulations and antimicrobial coatings, enhancing wound healing outcomes. The demand–supply balance is stable, though raw material cost fluctuations and production bottlenecks pose near-term risks. Key threats include regulatory scrutiny, economic downturns impacting healthcare budgets, and competition from alternative closure methods like adhesives. Strategic partnerships and R&D investments will be critical for sustained market penetration.

11 items

1. Executive Summary

2. Medical Monofilament Synthetic Absorbable Sutures Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Medical Monofilament Synthetic Absorbable Sutures Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Medical Monofilament Synthetic Absorbable Sutures Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Others

6.2. Global Medical Monofilament Synthetic Absorbable Sutures Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. With Needles

6.2.2. Without Needles

6.3. Global Medical Monofilament Synthetic Absorbable Sutures Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Medical Monofilament Synthetic Absorbable Sutures Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Medical Monofilament Synthetic Absorbable Sutures Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Medical Monofilament Synthetic Absorbable Sutures Market Competition by Key Manufacturers

8.1. Global Medical Monofilament Synthetic Absorbable Sutures Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Medical Monofilament Synthetic Absorbable Sutures: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Covidien (Medtronic)

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Johnson & Johnson

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. B. Braun

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Jianshi Medical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Huaiyin Medical

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Hangzhou Aipu Medical

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. JINHUAN MEDICAL

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Medical Monofilament Synthetic Absorbable Sutures Market

Figure 4: Global Medical Monofilament Synthetic Absorbable Sutures Market: Drivers

Figure 5: Global Medical Monofilament Synthetic Absorbable Sutures Market: Challenges

Figure 6: Global Medical Monofilament Synthetic Absorbable Sutures Market: Trends

Figure 7: Global Medical Monofilament Synthetic Absorbable Sutures Market: Opportunity

Figure 8: Global Medical Monofilament Synthetic Absorbable Sutures Market: Restraint

Figure 9: Global Medical Monofilament Synthetic Absorbable Sutures Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Medical Monofilament Synthetic Absorbable Sutures Market Value (USD Million) By Region

Figure 15: Global Medical Monofilament Synthetic Absorbable Sutures Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Medical Monofilament Synthetic Absorbable Sutures Market Value (USD Million) By Region

Figure 23: Global Medical Monofilament Synthetic Absorbable Sutures Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Medical Monofilament Synthetic Absorbable Sutures Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Medical Monofilament Synthetic Absorbable Sutures Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Medical Monofilament Synthetic Absorbable Sutures Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Medical Monofilament Synthetic Absorbable Sutures Market Value (USD Million) By Region

Table 10: Global Medical Monofilament Synthetic Absorbable Sutures Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Medical Monofilament Synthetic Absorbable Sutures Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Medical Monofilament Synthetic Absorbable Sutures Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Medical Monofilament Synthetic Absorbable Sutures Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Covidien (Medtronic) Basic Information And Sales Area

Table 31: Covidien (Medtronic). Products Portfolio

Table 32: Johnson & Johnson Basic Information And Sales Area

Table 33: Johnson & Johnson. Products Portfolio

Table 34: B. Braun Basic Information And Sales Area

Table 35: B. Braun. Products Portfolio

Table 36: Jianshi Medical Basic Information And Sales Area

Table 37: Jianshi Medical. Products Portfolio

Table 38: Huaiyin Medical Basic Information And Sales Area

Table 39: Huaiyin Medical. Products Portfolio

Table 40: Hangzhou Aipu Medical Basic Information And Sales Area

Table 41: Hangzhou Aipu Medical. Products Portfolio

Table 42: JINHUAN MEDICAL Basic Information And Sales Area

Table 43: JINHUAN MEDICAL. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global Medical Monofilament Synthetic Absorbable Sutures Market Value (USD Million) By Region

Table 49: Global Medical Monofilament Synthetic Absorbable Sutures Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Medical Monofilament Synthetic Absorbable Sutures Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	440.00 million
Revenue forecast in 2033	767.38 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Covidien (Medtronic); Johnson & Johnson; B. Braun; Jianshi Medical; Huaiyin Medical; Hangzhou Aipu Medical; JINHUAN MEDICAL
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options